Gennova Biopharmaceuticals’ Post

Recent research has indicated that the persistence of biofilms may be linked with aggravating the symptoms associated with common scalp conditions, such as dandruff and seborrheic dermatitis. Learn how DermaKB™ which uses Kane Biotech Inc.'s coactiv+™ technology, can help break down biofilms at: dermakb.com #biotech #biotechnology #biofilm #bacteria #shampoo #dandruff #seborrheicdermatitis #skin #scalp #kanebio #development #research

An interesting year, no doubt! - Collaborated with some great companies to help solve their long-term MSAT supply chain concerns (MANY THANKS FOR THE OPPORTUNITIES) - Launched a new website www.nu-tekbiosciences.com with our friends at That's Nice - Traveled to some new places - Switzerland & Spain to name two - Got the plant rolling - first dedicated animal-free greenfield plant in the states - 2024 is shaping up to be a great year as we look to support a sustainable future in cell culture with animal-free materials that provide the upside of supplements AND reduced variability CHEERS! #peptones #hydrolysates #yeastextract #bioscience #pharma #hydrolysate #biotechinnovation #biotech #biotechnology #cellculture #cellculturemedia #CHO #insectcellculture #pharma #pharmaceutical #innovation #productivity #sales #transparency #characterization

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with over 20,000 industry leaders from across the globe. As they say, it's where Business and Breakthroughs Converge. And I can't wait to be in San Diego with Morielle Mercelita-Cappo next week talking to you about how effective communication (internally and externally) can transform the buzz around your breakthroughs. #BIO2024 #Biotech

Join us at the #BioIT World Conference on April 17, 2024, where I will be engaging in an insightful panel discussion on fostering innovation and investment in the early stages of Biotech and Bio-IT. #BioITWorld #BiotechInnovation #InvestmentInScience

#BiotechInnovation: HTBA & Abolis' Groundbreaking Alliance in Polyphenol Production! HTBA (HealthTech BioActives) and Abolis Biotechnologies are setting new benchmarks in the bioactive compounds industry by revolutionizing the production of polyphenols. This strategic collaboration is poised to transform supply chain dynamics, enhance sustainability, and drive market expansion in the health sector. Strategic Impact & Market Dynamics: 🌿 Supply Chain Resilience: Transitioning from traditional extraction to microbial strain production mitigates raw material shortages and geopolitical risks. 🌿 Cost Efficiency & Scalability: The biotechnological approach significantly reduces production costs, meeting the rising global demand more effectively. 🌿 Market Expansion: Ability to produce rare polyphenols positions HTBA for leadership in the health and wellness sector. Innovation and Technological Advances: 🔬 Green Biotechnology: Leveraging microbial technology exemplifies innovation and aligns with global sustainability goals. 🔬 New Product Development: Potential for pioneering new polyphenols that could set industry standards. 🔬 Technological Synergies: Combining HTBA’s market knowledge with Abolis’ tech expertise fosters further sector-wide innovations. Investor Insights: 🧬 Biotech Innovations: Companies like HTBA and Abolis represent promising investment avenues due to their sustainable and innovative production technologies. 🧬 Sustainability Focus: Investing in firms prioritizing eco-friendly practices aligns with consumer trends and regulatory frameworks. 🧬 Long-Term Growth: Watch for expanding opportunities in functional foods, cosmetics, and pharmaceuticals as these technologies mature. The HTBA-Abolis alliance is not just a business move; it's a visionary stride towards sustainable, resilient, and cost-effective health product manufacturing. For investors and industry watchers, this is a pivotal moment to engage with a future where biotechnology reshapes market landscapes. Read More: https://lnkd.in/egnqWtY7 #HealthTech #SustainableManufacturing #Polyphenols #Biotechnology #MarketLeadership #InvestmentOpportunity #MarketUnwinded

Driving biotech advancement through IT innovation. Read how Saros Consulting collaborated with a global biotech company on a successful infrastructure project. Swipe for details! ➡️ To read the full case study, see the link in our comments below.   #Biotech #ITTransformation #ITInfrastructure #SarosConsulting #BusinessMadeBetter

Excited to share McKinsey’s latest report on the European biotech financing landscape based on our presentation at Bio€quity Europe 2024 a few weeks back. My key takeaway from the report? The biotech industry started 2024 with some positive trends on financing and these trends are bringing a sentiment of cautious optimism to both biotech companies and investors. Check out the infographic below for other key takeaways and read the report for more strategic implications and insights for investors and biotech companies alike: https://lnkd.in/d-6atERy #Biotech #BiotechInvestments #FutureOfBiotech #BioEquity

The importance of the biotech sector for the Czech innovative economy is not yet fully appreciated, but this is gradually improving and PRAGUE.BIO is an important driver of this change.  #bio #czechia #innovations #economy

Excited to share McKinsey’s latest report on the European biotech financing landscape based on our presentation at Bio€quity Europe 2024 a few weeks back. My key takeaway from the report? The biotech industry started 2024 with some positive trends on financing and these trends are bringing a sentiment of cautious optimism to both biotech companies and investors. Check out the infographic below for other key takeaways and read the report for more strategic implications and insights for investors and biotech companies alike: https://lnkd.in/gHfYPqyX #Biotech #BiotechInvestments #FutureOfBiotech #BioEquity